deferasirox orifarm 180 mg filmdragerad tablett
orifarm generics a/s - deferasirox - filmdragerad tablett - 180 mg - deferasirox 180 mg aktiv substans
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastiska medel - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
deferasirox sandoz 90 mg filmdragerad tablett
sandoz a/s - deferasirox - filmdragerad tablett - 90 mg - deferasirox 90 mg aktiv substans
deferasirox sandoz 360 mg filmdragerad tablett
sandoz a/s - deferasirox - filmdragerad tablett - 360 mg - deferasirox 360 mg aktiv substans
deferasirox sandoz 180 mg filmdragerad tablett
sandoz a/s - deferasirox - filmdragerad tablett - 180 mg - deferasirox 180 mg aktiv substans
deferasirox glenmark 180 mg filmdragerad tablett
glenmark arzneimittel gmbh - deferasirox - filmdragerad tablett - 180 mg - deferasirox 180 mg aktiv substans
deferasirox glenmark 90 mg filmdragerad tablett
glenmark arzneimittel gmbh - deferasirox - filmdragerad tablett - 90 mg - deferasirox 90 mg aktiv substans
deferasirox glenmark 360 mg filmdragerad tablett
glenmark arzneimittel gmbh - deferasirox - filmdragerad tablett - 360 mg - deferasirox 360 mg aktiv substans
deferasirox medical valley 360 mg filmdragerad tablett
medical valley invest ab - deferasirox - filmdragerad tablett - 360 mg - deferasirox 360 mg aktiv substans
deferasirox medical valley 90 mg filmdragerad tablett
medical valley invest ab - deferasirox - filmdragerad tablett - 90 mg - deferasirox 90 mg aktiv substans